Report Detail
Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2025
- RnM3154123 |
- 20 March, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Other
Global Sofosbuvir (CAS 1190307-88-0) market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sofosbuvir (CAS 1190307-88-0).
This report researches the worldwide Sofosbuvir (CAS 1190307-88-0) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Sofosbuvir (CAS 1190307-88-0) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
NIFTY LABS PVT LTD
DEAFARMA
Anhui HaiKang Pharmaceutical Co. Ltd
Haoyuan Chemexpress Co.Ltd
SMS Pharmaceuticals Limited
Beijing Kawin Technology Share-holding Co
Manus Aktteva Biopharma LLP
Hangzhou Longshine Bio-Tech Co
Tecoland
Sinobright Pharmaceutical Company Limited
Sofosbuvir (CAS 1190307-88-0) Breakdown Data by Type
≥ 98% Purity
＜ 98% Purity
Sofosbuvir (CAS 1190307-88-0) Breakdown Data by Application
400mg Tablets
Others
Sofosbuvir (CAS 1190307-88-0) Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Sofosbuvir (CAS 1190307-88-0) Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Sofosbuvir (CAS 1190307-88-0) capacity, production, value, consumption, status and forecast;
To focus on the key Sofosbuvir (CAS 1190307-88-0) manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Sofosbuvir (CAS 1190307-88-0) :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Sofosbuvir (CAS 1190307-88-0) Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Sofosbuvir (CAS 1190307-88-0) Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Type
- 1.4.2 ≥ 98% Purity
- 1.4.3 ＜ 98% Purity
- 1.5 Market by Application
- 1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size Growth Rate by Application
- 1.5.2 400mg Tablets
- 1.5.3 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Sofosbuvir (CAS 1190307-88-0) Production
- 2.1.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue 2014-2025
- 2.1.2 Global Sofosbuvir (CAS 1190307-88-0) Production 2014-2025
- 2.1.3 Global Sofosbuvir (CAS 1190307-88-0) Capacity 2014-2025
- 2.1.4 Global Sofosbuvir (CAS 1190307-88-0) Marketing Pricing and Trends
- 2.2 Sofosbuvir (CAS 1190307-88-0) Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Sofosbuvir (CAS 1190307-88-0) Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Sofosbuvir (CAS 1190307-88-0) Production by Manufacturers
- 3.1.1 Sofosbuvir (CAS 1190307-88-0) Production by Manufacturers
- 3.1.2 Sofosbuvir (CAS 1190307-88-0) Production Market Share by Manufacturers
- 3.2 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers
- 3.2.1 Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturers (2014-2019)
- 3.2.2 Sofosbuvir (CAS 1190307-88-0) Revenue Share by Manufacturers (2014-2019)
- 3.3 Sofosbuvir (CAS 1190307-88-0) Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Sofosbuvir (CAS 1190307-88-0) Production by Regions
- 4.1 Global Sofosbuvir (CAS 1190307-88-0) Production by Regions
- 4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production Market Share by Regions
- 4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Sofosbuvir (CAS 1190307-88-0) Production
- 4.2.2 United States Sofosbuvir (CAS 1190307-88-0) Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Sofosbuvir (CAS 1190307-88-0) Import & Export
- 4.3 Europe
- 4.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Production
- 4.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Sofosbuvir (CAS 1190307-88-0) Import & Export
- 4.4 China
- 4.4.1 China Sofosbuvir (CAS 1190307-88-0) Production
- 4.4.2 China Sofosbuvir (CAS 1190307-88-0) Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Sofosbuvir (CAS 1190307-88-0) Import & Export
- 4.5 Japan
- 4.5.1 Japan Sofosbuvir (CAS 1190307-88-0) Production
- 4.5.2 Japan Sofosbuvir (CAS 1190307-88-0) Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Sofosbuvir (CAS 1190307-88-0) Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
- 5.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
- 5.1.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Regions
- 5.1.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 5.2.2 North America Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 5.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 5.4.2 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 5.5.2 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 5.6.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Sofosbuvir (CAS 1190307-88-0) Breakdown Dada by Type
- 6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type
- 6.3 Sofosbuvir (CAS 1190307-88-0) Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Sofosbuvir (CAS 1190307-88-0) Breakdown Dada by Application
- 7.2.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption by Application
- 7.2.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 Teva Pharmaceutical Industries Ltd
- 8.1.1 Teva Pharmaceutical Industries Ltd Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.1.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.1.5 SWOT Analysis
- 8.2 DONG BANG FUTURE TECH & LIFE CO., LTD
- 8.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.2.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.2.5 SWOT Analysis
- 8.3 NIFTY LABS PVT LTD
- 8.3.1 NIFTY LABS PVT LTD Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.3.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.3.5 SWOT Analysis
- 8.4 DEAFARMA
- 8.4.1 DEAFARMA Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.4.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.4.5 SWOT Analysis
- 8.5 Anhui HaiKang Pharmaceutical Co. Ltd
- 8.5.1 Anhui HaiKang Pharmaceutical Co. Ltd Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.5.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.5.5 SWOT Analysis
- 8.6 Haoyuan Chemexpress Co.Ltd
- 8.6.1 Haoyuan Chemexpress Co.Ltd Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.6.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.6.5 SWOT Analysis
- 8.7 SMS Pharmaceuticals Limited
- 8.7.1 SMS Pharmaceuticals Limited Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.7.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.7.5 SWOT Analysis
- 8.8 Beijing Kawin Technology Share-holding Co
- 8.8.1 Beijing Kawin Technology Share-holding Co Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.8.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.8.5 SWOT Analysis
- 8.9 Manus Aktteva Biopharma LLP
- 8.9.1 Manus Aktteva Biopharma LLP Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.9.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.9.5 SWOT Analysis
- 8.10 Hangzhou Longshine Bio-Tech Co
- 8.10.1 Hangzhou Longshine Bio-Tech Co Company Details
- 8.10.2 Company Description
- 8.10.3 Capacity, Production and Value of Sofosbuvir (CAS 1190307-88-0)
- 8.10.4 Sofosbuvir (CAS 1190307-88-0) Product Description
- 8.10.5 SWOT Analysis
- 8.11 Tecoland
- 8.12 Sinobright Pharmaceutical Company Limited
9 Production Forecasts
- 9.1 Sofosbuvir (CAS 1190307-88-0) Production and Revenue Forecast
- 9.1.1 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast 2019-2025
- 9.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast 2019-2025
- 9.2 Sofosbuvir (CAS 1190307-88-0) Production and Revenue Forecast by Regions
- 9.2.1 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Regions
- 9.2.2 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Regions
- 9.3 Sofosbuvir (CAS 1190307-88-0) Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Sofosbuvir (CAS 1190307-88-0) Production Forecast by Type
- 9.4.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Sofosbuvir (CAS 1190307-88-0) Upstream Market
- 11.1.1 Sofosbuvir (CAS 1190307-88-0) Key Raw Material
- 11.1.2 Typical Suppliers of Key Sofosbuvir (CAS 1190307-88-0) Raw Material
- 11.1.3 Sofosbuvir (CAS 1190307-88-0) Raw Material Market Concentration Rate
- 11.2 Sofosbuvir (CAS 1190307-88-0) Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Sofosbuvir (CAS 1190307-88-0) Distributors
- 11.5 Sofosbuvir (CAS 1190307-88-0) Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Sofosbuvir (CAS 1190307-88-0) . Industry analysis & Market Report on Sofosbuvir (CAS 1190307-88-0) is a syndicated market report, published as Global Sofosbuvir (CAS 1190307-88-0) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sofosbuvir (CAS 1190307-88-0) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
